Skip to main content

Nexien Biopharma, Inc.

NXENDelisted
Industry
Pharmaceutical Preparations
SEC CIK
0001625288

Nexien Biopharma, Inc. was delisted in 2024; its insiders filed their last Form 4 on May 28, 2024; no institution reported holding it in 13F filings for Q3 2024; no superinvestor held it.

Holders of 5% or more of NXEN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Nexien Biopharma, Inc., largest stake first. The change is against the holder's previous filing.

No holder currently reports owning 5% or more of Nexien Biopharma, Inc. on Schedule 13D or 13G.

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

Schedule 13D and 13G filings on Nexien Biopharma, Inc., newest first.

No Schedule 13D or 13G filings on Nexien Biopharma, Inc. are on file.

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Nexien Biopharma, Inc. shares.

No Form 144 notices for Nexien Biopharma, Inc. are on file.